Abbott wins FDA approval for TactiFlex Duo dual-energy AFib ablation catheter

• FDA cleared Abbott’s TactiFlex Duo ablation catheter for atrial fibrillation, supporting treatment of complex cases with dual-energy PFA and RF.
• Clearance strengthens Abbott’s pulsed field ablation portfolio; broader US commercial rollout expected in coming weeks.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbott Laboratories published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609080800PR_NEWS_USPR_____CG41383) on September 08, 2026, and is solely responsible for the information contained therein.